Quick Answer
Beneficient reported Cash And Cash Equivalents At Carrying Value of $1.35 million for the year ending 2025.
- Beneficient showed a decrease of -83.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Beneficient's annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $3.06 million | Q3 2023: $2.39 million | Q4 2023: $11.25 million | Q2 2024: $4.40 million | Q3 2024: $4.48 million | Q4 2024: $4.15 million | Q1 2025: $1.35 million | Q2 2025: $7.61 million | Q3 2025: $4.90 million | Q4 2025: $7.87 million.
- Over the full 4 years of available data (2022 to 2025), Beneficient's Cash And Cash Equivalents At Carrying Value has declined by 98.1%.
- Historical annual values: Fiscal year 2025: $1.35 million | Fiscal year 2024: $7.91 million | Fiscal year 2023: $8.73 million | Fiscal year 2022: $70.59 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: